Showing results (431-440 of 1,086) with videos related to

Sort By:
Pageof 109
Journal of the American Heart Association|May 6, 2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 GenotypingLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
Journal of the American College of Cardiology|September 6, 2014
Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery diseaseDominick J Angiolillo, Joseph A Jakubowski, José Luis Ferreiro, et al.
European Heart Journal|March 29, 2023
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleedingDavide Cao, Nicolas Amabile, Mauro Chiarito, et al.
The Canadian Journal of Cardiology|February 10, 2015
Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insightsFernando Rivero, Teresa Bastante, Javier Cuesta, et al.
JACC. Case Reports|April 18, 2025
Rotorbitripsy: "Ménage à Trois" for the Management of Coronary CalcificationDavid Del Val, Teresa Bastante, Alexander Marschall, et al.
Journal of Cardiovascular Development and Disease|May 24, 2024
Development and Clinical Application of Left Ventricular-Arterial Coupling Non-Invasive Assessment MethodsAlvaro Gamarra, Pablo Díez-Villanueva, Jorge Salamanca, et al.
World Neurosurgery|September 26, 2021
Severe, Intolerable Fatigue Associated with Hyperresponse to ClopidogrelDavid I Bass, Christopher C Young, Min S Park, et al.
JACC. Cardiovascular Interventions|March 18, 2014
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patientsFabiana Rollini, Francesco Franchi, Antonio Tello-Montoliu, et al.
Pageof 109